HomeMRVL • CVE
add
Marvel Biosciences Corp
Nakaraang pagsara
$0.18
Sakop ng taon
$0.060 - $0.19
Market cap
7.19M CAD
Average na Volume
82.08K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(CAD) | Abr 2024info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 228.70K | -65.05% |
Net na kita | -307.31K | 57.10% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CAD) | Abr 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 217.69K | -78.28% |
Kabuuang asset | 347.27K | -71.54% |
Kabuuang sagutin | 3.10M | 77.51% |
Kabuuang equity | -2.76M | — |
Natitirang share | 39.79M | — |
Presyo para makapag-book | -2.50 | — |
Return on assets | -108.04% | — |
Return on capital | 51.70% | — |
Cash Flow
Net change in cash
(CAD) | Abr 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -307.31K | 57.10% |
Cash mula sa mga operasyon | -359.98K | -21.56% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | -359.98K | -151.14% |
Malayang cash flow | -217.51K | -1,808.33% |
Tungkol
Itinatag
2021
Headquarters
Website